Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

10596	Companies
224704	Keywords
153398	Articles
118849	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 04/29/2025 at 19:00, 1 year 1 month ago

THERANEXUS PUBLISHES ITS 2024 FULL-YEAR RESULTS, PRESENTS ITS PROGRESS REPORT AND CLOSES ITS EQUITY LINE
Theranexus publishes financial results for 2024 & cash position as of March 31, 2025, presents progress report & plans for Batten-1 drug candidate. Board approves accounts. Continues strategic partnerships & developments

Financial Results Strategic Partnerships Clinical Trials Theranexus Batten-1
BRIEF

published on 03/06/2025 at 18:05, 1 year 3 months ago

Modification of the Theranexus liquidity contract

Liquidity Contract AMF PORTZAMPARC Theranexus Rare Neurological Diseases
BRIEF

published on 01/31/2025 at 18:10, 1 year 4 months ago

Half-yearly report on Theranexus' liquidity contract with Portzamparc

Liquidity Contract Transactions PORTZAMPARC Half-yearly Report Theranexus
BRIEF

published on 01/30/2025 at 18:05, 1 year 4 months ago

Theranexus Strengthens its Treasury and Develops its Partnerships

Treasury Theranexus Neurological Diseases Exeltis Partnership Bpifrance Financing
PRESS RELEASE

published on 01/30/2025 at 18:00, 1 year 4 months ago

THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT
Theranexus announces cash position of €4.0 M as of 29 January 2025, strengthening financial outlook. Biopharmaceutical company progressing on rare neurological disease treatments, including Niemann-Pick and Gaucher diseases

Cash Position Biopharmaceutical Financial Outlook Theranexus Neurological Diseases
BRIEF

published on 01/23/2025 at 18:20, 1 year 4 months ago

Theranexus Unveils 2025 Financial Calendar

Financial Calendar Biopharmaceutical Theranexus Neurological Diseases 2025 Schedule
PRESS RELEASE

published on 01/23/2025 at 18:15, 1 year 4 months ago

THERANEXUS ANNOUNCES ITS FINANCIAL CALENDAR FOR 2025
Theranexus, a biopharmaceutical company in rare neurological disease treatment, announces its 2025 financial communication agenda for Euronext market. Dates subject to change

Euronext Biopharmaceutical Financial Communication Theranexus Neurological Diseases
BRIEF

published on 01/23/2025 at 18:05, 1 year 4 months ago

Theranexus Announces its Financial Agenda for 2025

Euronext Paris Financial Agenda Theranexus Financial Publications Neurological Diseases
BRIEF

published on 01/16/2025 at 18:05, 1 year 5 months ago

Theranexus: Monthly update of voting rights and shares

Voting Rights Actions Stock Market Biopharmaceutical Theranexus
BRIEF

published on 01/09/2025 at 18:05, 1 year 5 months ago

Theranexus Publishes its Letter to Shareholders

Financial Outlook Theranexus Rare Neurological Diseases Letter To Shareholders Innovative Platform

Accesswire

Published on 06/18/2026 at 13:30, 27 minutes ago

Spirit Blockchain Capital Announces Shares For Services Issuance
Published on 06/18/2026 at 13:30, 27 minutes ago

ZTEST Electronics Inc. Announces Leadership Transition, Appoints New Director and Chair
Published on 06/18/2026 at 13:00, 57 minutes ago

Formation Metals Extends A-Zone 200 Metres West of Historic Resource into Previously Undrilled Ground, Returning 1.05 g/t Au over 31 Metres at the Advanced N2 Gold Project
Published on 06/18/2026 at 13:00, 57 minutes ago

Silver Storm Receives La Parrilla Surface Drilling Permits
Published on 06/18/2026 at 12:30, 1 hour 27 minutes ago

Relevant Gold South Pass VTEM Survey Defines Multi-Kilometre Structural Corridors with High Priority Drill Targets

View all ACCESSWIRE

EQS Group

Published on 06/18/2026 at 13:05, 52 minutes ago

Claros Technologies Appoints Jack Cogen to Board of Directors
Published on 06/18/2026 at 13:05, 52 minutes ago

MMDSmart MessageWhiz Launches On Zoho Marketplace To Extend Automated Omnichannel Messaging Inside Zoho CRM
Published on 06/18/2026 at 12:55, 1 hour 2 minutes ago

FP Markets Wins Most Trusted Broker at the Global UF Awards 2026
Published on 06/18/2026 at 12:45, 1 hour 12 minutes ago

Hong Kong rises to No.2 globally in competitiveness
Published on 06/18/2026 at 12:12, 1 hour 45 minutes ago

Form 8.3 - Advanced Medical Solutions Group Plc

Les Echos

Published on 06/18/2026 at 13:00, 57 minutes ago

Edenred statement
Published on 06/18/2026 at 09:06, 4 hours 51 minutes ago

Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 5 hours 27 minutes ago

OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 6 hours 57 minutes ago

bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 20 hours 17 minutes ago

Report on share repurchases from 10 to 16 June 2026

View all LES ECHOS COMFI WIRE